Letters Journal’s withdrawal of article

Concerns about methods used

BMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.d2722 (Published 10 May 2011) Cite this as: BMJ 2011;342:d2722
  1. Barry J Goldstein, vice president of clinical research, diabetes and endocrinology1
  1. 1Merck Research Laboratories, Rahway, New Jersey, USA
  1. barry.goldstein{at}merck.com

I would like to share some information regarding the BMJ news article about a draft “article in press” recently withdrawn from the Gastroenterology website.1

Merck/MSD encourages and supports scientific discussion and debate that contributes to the ongoing care of patients with type …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe